Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF CASH FLOWS (As Restated)

v3.22.2.2
STATEMENTS OF CASH FLOWS (As Restated) - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net loss $ (14,682,592) $ (72,459,185)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (6,639,430) (2,516,752)
Transaction costs attributable to Initial Public Offering 1,125,634  
Loss on derivative liabilities 18,250,000 73,583,549
Unrealized gain on marketable securities held in Trust Account (45,988) (1,276)
Deferred income tax (benefit) provision 9,657 (8,681)
Changes in operating assets and liabilities:    
Prepaid expenses (275,525) 181,226
Prepaid income taxes (27,140) 27,140
Accounts payable and accrued expenses 257,466 378,017
Income tax payable   95,302
Net cash used in operating activities (2,027,918) (720,660)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (690,000,000)  
Cash withdrawn from Trust Account for working capital 125,000 250,000
Cash withdrawn from Trust Account to pay franchise and income taxes 1,265,000 606,250
Net cash provided by (used in) investing activities (688,610,000) 856,250
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B common stock to Sponsor 25,000  
Proceeds from sale of Units, net of underwriting discounts paid 677,788,000  
Proceeds from sale of Private Placement Warrants 15,800,000  
Proceeds from promissory notes - related party 200,000 1,500,000
Repayment of promissory notes - related party (200,000)  
Payment of offering costs (736,807)  
Net cash provided by financing activities 692,876,193 1,500,000
Net Change in Cash 2,238,275 1,635,590
Cash - Beginning   2,238,275
Cash - Ending 2,238,275 3,873,865
Supplemental cash flow information:    
Cash paid for income taxes 1,265,000 373,000
Non-cash investing and financing activities:    
Remeasurement of Class A common stock subject to redemption 60,431,476 $ 1,571,228
Deferred underwriting fee payable $ 21,371,000